Able-bodied person
Conditions
Interventions
Take 4 types of food containing active ingredients once each
Take 4 types of food containing active ingredients once each
Take 4 types of food containing active ingredients once each
Take 4 types of f
Sponsors
Macromill, Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Japanese men and women aged 20 to 65 years at the time of consent 2) Healthy individuals not undergoing any treatment 3) BMI 18.5 kg/m2 or greater and less than 25.0 kg/m2 4) Able to attend designated examinations and complete records 5) Subjects who have received a full explanation of the study's purpose and contents and voluntarily agreed to participate in the study in writing
Exclusion criteria
Exclusion criteria: 1) Subjects with a history of digestive problems 2) Subjects with drug or food allergies 3) Subjects with hypersensitivity to the experimental foods 4) Subjects who are pregnant or breastfeeding 5) Subjects who have had more than 200 ml of blood drawn within one month prior to the date of consent or more than 400 ml within three months 6) Subjects who drink more than 20g of alcohol per day 7) Subjects who smoke 8) Subjects who regularly use supplements and vitamin preparations (including intravenous drips/injections) 9) Subjects who cannot refrain from taking foods for specified health uses, foods with functional claims, or other so-called health foods during the study period 10) Subjects who cannot take the experimental foods as instructed 11) Subjects who work night shifts or shift work 12) Subjects with renal dysfunction 13) Subjects who are participating in other clinical trials, clinical research, or clinical studies 14) Subjects who cannot follow the instructions of the principal investigator, or who the principal investigator deems inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood concentration of active ingredients after ingestion of experimental foods | — |
Secondary
| Measure | Time frame |
|---|---|
| Total antioxidant capacity, Adverse events | — |
Countries
Japan
Contacts
Public ContactMinami Hanaoka
Macromill, Inc. Life Science Division
Outcome results
None listed